why choose us

First received: June 19, 2024

Clinical Trial: Efficacy and Safety of Early Initiation of Butylphthalide Treatment in Patients With Acute Ischemic Stroke.

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Acute Ischemic Stroke

Study Type: INTERVENTIONAL


Official Title: Effect of Early Initiation of Butylphthalide on Neural Function in Patients With Acute Ischemic Stroke -A Prospective, Multicenter, Randomized, Open-label, Blinded End Trial

Brief Summary: This study is a prospective, multicenter, randomized, open-label, blinded-endpoint trial designed to evaluate the difference in efficacy of Butylphthalide Sodium Chloride Injection treatment initiated early (<3 hours) versus late (3-6 hours) in patients with acute ischemic stroke.The aim is to determine the optimal timing window for neuroprotective therapy.

Read more